DECREASE OF TRANSPLANTABILITY BY THE IMMUNOPOTENTIATORS, OK-432 AND INTERLEUKIN-2 - EXPERIMENTS ON A HUMAN HEPATOMA-CELL LINE IN NUDE-MICE

被引：4

作者：

SAITO, H ^{[1
]}

MORIZANE, T ^{[1
]}

INAGAKI, Y ^{[1
]}

KUMAGAI, N ^{[1
]}

WATANABE, T ^{[1
]}

NAKAMURA, T ^{[1
]}

SATOH, I ^{[1
]}

SAWAGUCHI, K ^{[1
]}

IWABUCHI, N ^{[1
]}

TSUCHIMOTO, K ^{[1
]}

TSUCHIYA, M ^{[1
]}

机构：

[1] KEIO UNIV,SCH MED,DEPT INTERNAL MED,35 SHINANOMACHI,SHINJUKU KU,TOKYO 160,JAPAN

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1989年 / 25卷 / 01期

关键词：

D O I：

10.1016/0277-5379(89)90054-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：79 / 89

页数：11

共 33 条

[21] ANTITUMOR EFFECT OF RECOMBINANT HUMAN INTERLEUKIN-2 ON THE GROWTH OF MURINE HEMANGIOENDOTHELIOMA-D14 IN NUDE-MICE - OCCURRENCE OF LARGE GRANULAR CELLS IN THE TUMOR
SAKURA, Y
HOUKAN, T
OOTSU, K
SHINO, A
JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (08): : 950 - 957
[22] IN-VIVO SYSTEM TO DETECT LONG-TERM CONTINUOUS RELEASE OF BIOACTIVE INTERLEUKIN-2 BY IMMUNOPHARMACOLOGICAL DEPOT PREPARATIONS IN NUDE-MICE WITH HUMAN TUMORS
HULAND, E
FALK, B
HUBNER, D
HULAND, H
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1995, 121 (05) : 285 - 290
[23] CHARACTERISTICS OF MOUSE LYMPHOID-CELLS PROLIFERATING INVITRO BY RECOMBINANT HUMAN INTERLEUKIN-2 (TGP-3) - COMPARISON BETWEEN NORMAL AND NUDE-MICE
HINUMA, S
NARUO, K
SHIHO, O
TSUKAMOTO, K
MICROBIOLOGY AND IMMUNOLOGY, 1989, 33 (09) : 761 - 773
[24] ESTROGENS INDUCE LOW-DENSITY-LIPOPROTEIN RECEPTOR ACTIVITY AND DECREASE INTRACELLULAR CHOLESTEROL IN HUMAN HEPATOMA-CELL LINE HEP-G2
SEMENKOVICH, CF
OSTLUND, RE
BIOCHEMISTRY, 1987, 26 (16) : 4987 - 4992
[25] A SUBCLONE OF THE HUMAN HEPATOMA-CELL LINE HEPG2 IS DEFECTIVE IN INTERLEUKIN-1-BETA-MEDIATED ACUTE PHASE GENE-EXPRESSION
PERLMUTTER, DH
FALLON, RJ
CLINICAL RESEARCH, 1989, 37 (02): : A539 - A539
[26] EFFECTS OF LYMPHOKINE-ACTIVATED KILLER CELLS AND INTERLEUKIN-2 ON THE ASCITES FORMATION AND THE SURVIVAL-TIME OF NUDE-MICE BEARING HUMAN OVARIAN-CANCER CELLS
OOMORI, K
KIKUCHI, Y
MIYAUCHI, M
KITA, T
IWANO, I
KIZAWA, I
HIRATA, J
KUKI, E
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1989, 115 (03) : 217 - 220
[27] A CYTOKINE-SELECTIVE DEFECT IN INTERLEUKIN-1-BETA-MEDIATED ACUTE PHASE GENE-EXPRESSION IN A SUBCLONE OF THE HUMAN HEPATOMA-CELL LINE (HEPG2)
PERLMUTTER, DH
COLTEN, HR
ADAMS, SP
MAY, LT
SEHGAL, PB
FALLON, RJ
JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (13) : 7669 - 7674
[28] EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-2 AND TUMOR-NECROSIS-FACTOR-ALPHA WITH OR WITHOUT INTERFERON-GAMMA ON HUMAN THYROID TISSUES FROM PATIENTS WITH GRAVES-DISEASE AND FROM NORMAL SUBJECTS XENOGRAFTED INTO NUDE-MICE
KASUGA, Y
MATSUBAYASHI, S
AKASU, F
MILLER, N
JAMIESON, C
VOLPE, R
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (06): : 1296 - 1301
[29] ANTITHROMBIN-III PRODUCTION BY THE HUMAN HEPATOMA-CELL LINE HEPG2 IS DECREASED BY INTERLEUKIN-6 AND INTERLEUKIN-1-BETA - ANTITHROMBIN-III ACTS AS A NEGATIVE ACUTE-PHASE PROTEIN
LAMPING, RJ
NIESSEN, RWLM
PETERS, M
STURK, A
THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1251 - 1251
[30] RADIOIMMUNOTHERAPY OF NUDE-MICE BEARING A HUMAN INTERLEUKIN-2 RECEPTOR ALPHA-EXPRESSING LYMPHOMA UTILIZING THE ALPHA-EMITTING RADIONUCLIDE-CONJUGATED MONOCLONAL-ANTIBODY BI-212-ANTI-TAC
HARTMANN, F
HORAK, EM
GARMESTANI, K
WU, CC
BRECHBIEL, MW
KOZAK, RW
TSO, J
KOSTEINY, SA
GANSOW, OA
NELSON, DL
WALDMANN, TA
CANCER RESEARCH, 1994, 54 (16) : 4362 - 4370

← 1 2 3 4 →